Condition: Pulmonary Embolism · Chronic Thromboembolic Pulmonary Hypertension · Chronic Thromboembolic Pulmonary Disease · Sponsor: China-Japan Friendship Hospital
The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.
This description comes directly from the study's public registry record.
Min Liu, PhD · +86-10-84205056 · mikie0763@126.com
Always discuss trial participation with your own doctor first.
| China-Japan Frendship hospital | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06526468